Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HuR counteracts miR-330 to promote STAT3 translation during inflammation-induced muscle wasting.
Mubaid S, Ma JF, Omer A, Ashour K, Lian XJ, Sanchez BJ, Robinson S, Cammas A, Dormoy-Raclet V, Di Marco S, Chittur SV, Tenenbaum SA, Gallouzi IE. Mubaid S, et al. Among authors: cammas a. Proc Natl Acad Sci U S A. 2019 Aug 27;116(35):17261-17270. doi: 10.1073/pnas.1905172116. Epub 2019 Aug 12. Proc Natl Acad Sci U S A. 2019. PMID: 31405989 Free PMC article.
HuR and miR-1192 regulate myogenesis by modulating the translation of HMGB1 mRNA.
Dormoy-Raclet V, Cammas A, Celona B, Lian XJ, van der Giessen K, Zivojnovic M, Brunelli S, Riuzzi F, Sorci G, Wilhelm BT, Di Marco S, Donato R, Bianchi ME, Gallouzi IE. Dormoy-Raclet V, et al. Among authors: cammas a. Nat Commun. 2013;4:2388. doi: 10.1038/ncomms3388. Nat Commun. 2013. PMID: 24005720 Free PMC article.
G-Quadruplexes in RNA Biology: Recent Advances and Future Directions.
Dumas L, Herviou P, Dassi E, Cammas A, Millevoi S. Dumas L, et al. Among authors: cammas a. Trends Biochem Sci. 2021 Apr;46(4):270-283. doi: 10.1016/j.tibs.2020.11.001. Epub 2020 Dec 7. Trends Biochem Sci. 2021. PMID: 33303320 Free article. Review.
Formation of the eIF4F translation-initiation complex determines sensitivity to anticancer drugs targeting the EGFR and HER2 receptors.
Zindy P, Bergé Y, Allal B, Filleron T, Pierredon S, Cammas A, Beck S, Mhamdi L, Fan L, Favre G, Delord JP, Roché H, Dalenc F, Lacroix-Triki M, Vagner S. Zindy P, et al. Among authors: cammas a. Cancer Res. 2011 Jun 15;71(12):4068-73. doi: 10.1158/0008-5472.CAN-11-0420. Epub 2011 Apr 15. Cancer Res. 2011. PMID: 21498638
24 results